Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)

NCT02452892 is registered in ClinicalTrials.gov with Tal Medical, Inc. as lead sponsor.

NCT NCT02452892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02452892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
Lead sponsor
Tal Medical, Inc.
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2015
Completion date
October 31, 2016
Enrollment
122 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

depression, depressive disorder, depressive disorder, major, depressive disorder, treatment-resistant